Abilify Compulsive Gambling Lawsuits Move Forward in Florida Federal Court

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Abilify Compulsive Gambling Lawsuits Move Forward in Florida Federal Court

Dozens of Abilify compulsive gambling lawsuits were centralized in a Florida federal court on October 3, 2016.

These cases were filed on behalf of individuals who experienced significant financial and mental losses after taking the antipsychotic drug Abilify.

Abilify compulsive gambling lawsuits have been filed against the manufacturers of the drug, Bristol-Myers Squibb Co., and Otsuka Pharmaceutical.

Abilify use linked to compulsive gambling

The Abilify lawsuits pending in 14 districts were consolidated into multidistrict litigation (MDL) in Florida in an effort to:

  • Eliminate duplicative discovery
  • Conserve court resources
  • Prevent inconsistent pretrial rulings.

The cases were consolidated before Chief Judge M. Casey Rodgers, who is already presiding over two Abilify cases in Florida’s Northern District in Pensacola.

Table of Contents

Abilify Compulsive Gambling Lawsuit

Product liability lawsuits against the Abilify makers allege that the companies withheld information from consumers.

Furthermore, the lawsuits allege that medical professionals were not informed about how Abilify use can lead to compulsive gambling and other compulsive behaviors.

The plaintiffs in many of these cases claim pathological gambling activity, loss of employment, severe damage to financial stability, and other mental and physical damages as a result of their Abilify use.

Their gambling problems typically ended soon after they stopped the medication.

Did the FDA warn about the Compulsive Gambling Risk with Abilify?

Despite the fact that the European FDA (European Medicines Agency) required Abilify warnings about the risk of compulsive gambling starting in 2012 and regulatory officials in Canada mandated similar warnings in late 2015, such warnings were not provided to consumers in the U.S. until May of 2016.

On May 3, 2016, the FDA issued a warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of Abilify.

How Does the Drug Abilify Work?

Abilify (aripiprazole) is an antipsychotic drug that was approved by the FDA in 2002.

The medication is used to treat schizophrenia, bipolar disorder, depression, and autism spectrum disorders.

Abilify has generated sales of more than $6 billion per year and was the top selling brand name drug on the market in 2013.

In 2014, a study published in the medical journal JAMA Internal Medicine reported evidence that dopamine receptor agonists (often used to treat Parkinson’s Disease) were linked to gambling and other impulse-control problems, the same behavioral problems associated with Abilify use.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources